 | • レポートコード：MRC2303I0140 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界のてんかん用モニタリングデバイス市場規模が、予測期間中（2022年〜2027年）に年平均4.1%で成長すると予測しています。本レポートは、てんかん用モニタリングデバイスの世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（従来型デバイス、ウェアラブルデバイス）分析、技術別（迷走神経刺激、脳深部刺激、加速度計、応答性神経刺激）分析、検出方法別（脳卒中脳波計、頭蓋内脳波計、表面筋電図、ビデオ検出装置）分析、エンドユーザー別（病院＆外来サービス、神経センター、診断センター）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などを以下の構成でまとめています。また、Medpage Ltd、Boston Scientific Corporation、Cadwell industries、Compumedics USA inc、Emfit Corporation、Empatica Inc、General Electric company、Kninklijke Philips N.V.、Masimo、Neurosoft、Neurowave systems、Nihon Kohden Corporation、Noninなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のてんかん用モニタリングデバイス市場規模：製品別 - てんかん用従来型デバイスの市場規模 - てんかん用ウェアラブルデバイスの市場規模 ・世界のてんかん用モニタリングデバイス市場規模：技術別 - 迷走神経刺激技術の市場規模 - 脳深部刺激技術の市場規模 - 加速度計の市場規模 - 応答性神経刺激技術の市場規模 ・世界のてんかん用モニタリングデバイス市場規模：検出方法別 - 脳卒中脳波計の市場規模 - 頭蓋内脳波計の市場規模 - 表面筋電図の市場規模 - ビデオ検出装置の市場規模 ・世界のてんかん用モニタリングデバイス市場規模：エンドユーザー別 - 病院＆外来サービスにおける市場規模 - 神経センターにおける市場規模 - 診断センターにおける市場規模 ・世界のてんかん用モニタリングデバイス市場規模：地域別 - 北米のてんかん用モニタリングデバイス市場規模 アメリカのてんかん用モニタリングデバイス市場規模 カナダのてんかん用モニタリングデバイス市場規模 メキシコのてんかん用モニタリングデバイス市場規模 … - ヨーロッパのてんかん用モニタリングデバイス市場規模 ドイツのてんかん用モニタリングデバイス市場規模 イギリスのてんかん用モニタリングデバイス市場規模 フランスのてんかん用モニタリングデバイス市場規模 … - アジア太平洋のてんかん用モニタリングデバイス市場規模 中国のてんかん用モニタリングデバイス市場規模 日本のてんかん用モニタリングデバイス市場規模 インドのてんかん用モニタリングデバイス市場規模 … - 中東/南米のてんかん用モニタリングデバイス市場規模 南アフリカのてんかん用モニタリングデバイス市場規模 ブラジルのてんかん用モニタリングデバイス市場規模 アルゼンチンのてんかん用モニタリングデバイス市場規模 … - その他地域のてんかん用モニタリングデバイス市場規模 ・競争状況 ・市場機会・将来の動向 |
The Epilepsy Monitoring Devices Market is projected to register a CAGR of 4.1% during the forecast period (2022-2027).
COVID-19 is expected to have a positive impact on the global demand for epilepsy monitoring devices in its latter phase since the population with epilepsy was at a higher risk of encountering fatalities. This is mainly due to the increasing incidences of seizures and epilepsy among the people who were affected by COVID-19 disease. According to the data published by the American Epilepsy Society (AES) in December 2021, patients with epilepsy were nearly 1.5 times more likely to die of COVID-19 than other infected patients. These circumstances have increased the demand for epilepsy monitoring devices to opt for treatments early on. Thus, COVID-19 is expected to have a considerable impact on the growth of the market.
Increasing incidences of epilepsy among people across the world are expected to drive the growth of the epilepsy monitoring devices market. According to the World Health Organization’s February 2022 update, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. It also reported that nearly 80% of people with epilepsy live in low- and middle-income countries. The same source also reported that it is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. Therefore, the increasing incidences of epilepsy cases across the globe are expected to increase the demand for epilepsy monitoring devices as they provide critical insights into the type of seizures. Furthermore, the increase in the geriatric population vulnerable to developing epilepsy and seizures across the globe also plays a crucial role in driving the market’s growth.
Additionally, the investment by the market players and advancements in technology are also propelling the growth of the market. For instance, in July 2022, Breakthrough Victoria invested in Victorian medical technology group Seer Medical to support its plan to become one of the global leaders in epilepsy home monitoring and management. The contribution will allow Seer to nearly double its workforce and footprint in Victoria while expanding into the United States and the United Kingdom.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and unfavorable reimbursement policies may hinder the growth of the market.
Epilepsy Monitoring Devices Market Trends
The Conventional Devices Segment is Expected to Hold a Major Market Share Over the Forecast Period
The conventional devices segment is expected to hold a significant share in the market owing to its safety and efficiency. Conventional devices refer to electroencephalogram (EEG) devices used for the continuous monitoring of patients.
Amid COVID-19, the demand for epilepsy monitoring devices was increasing as there was a higher prevalence of epilepsy among infected patients. For instance, according to the study titled “Epilepsy during the COVID‐19 pandemic lockdown: a US population survey” published in June 2021, 25% of people in the United States reported an increase in seizure cases during the pandemic period. Hence, such incidents boosted the demand for conventional devices for epilepsy monitoring during COVID-19 owing to their popularity and adoption within the patient population.
Additionally, conventional devices are widely used in hospitals and clinics for continuous monitoring purposes. Conventional devices provide a proper diagnosis to professionals about the type of seizure to prescribe the appropriate treatment. These factors can be attributed to the increasing demand for continuous, non-invasive monitoring of epilepsy.
Furthermore, in December 2021, iMediSync showcased its comprehensive EEG solution (hardware + software + remote telehealth solution) iSyncWave to perform brain mental health screening and predictive analysis of potential mental conditions in just 10 minutes. The presence of such advanced products in the market also contributes to the growth of the segment.
Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
The high incidences of neurological disorders, especially epilepsy, and a large number of end-users in the United States are the major factors for the growth of epilepsy monitoring devices in this region.
According to the article titled “Epidemiology of status epilepticus in the United States: A systematic review” published in November 2020, the incidence of all status epilepticus in patients of all ages in the United States ranged from 18.3 to 41 per 100,000 people per year. Such a high burden of epilepsy has contributed to the increase in the demand for epilepsy monitoring devices to provide proper treatment to patients.
Furthermore, the presence of the major market players in this region and their spending extensively on research and development of new products is also expected to boost the growth of the market in this region. For instance, in January 2021, BioSerenity received 510(k) clearance for its electroencephalography (EEG) wearable device system from the United States Food and Drug Administration (FDA). This clearance includes BioSerenity’s NeuronauteEEG system and IceCap EEG wearable device, which are intended to allow physicians to remotely monitor and assess the electrical brain activity of people living with epilepsy.
Thus, owing to the abovementioned factors, the studied market is expected to show growth in the North American region.
Epilepsy Monitoring Devices Market Competitor Analysis
The Epilepsy Monitoring Devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Medpage Ltd, Boston Scientific Corporation, Cadwell Industries, Compumedics USA inc., Emfit Corporation, Empatica Inc., General Electric company, Koninklijke Philips N.V., Masimo, Neurosoft, Neurowave systems, Nihon Kohden Corporation, Nonin, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing incidence of Epilepsy
4.2.2 Rising awareness of neurodegenerative disorders, including epilepsy
4.3 Market Restraints
4.3.1 High cost of the equipment
4.3.2 Unfavourable Reimbursement policies
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – in USD million)
5.1 By Product
5.1.1 Conventional devices
5.1.2 Wearable devices
5.2 By Technology
5.2.1 Vagus nerve stimulation
5.2.2 Deep brain stimulation
5.2.3 Accelometry
5.2.4 Responsive neurostimulation
5.3 By Detection
5.3.1 Elecetroencephalogram
5.3.2 Intracranial EEG
5.3.3 Surface Electromyography
5.3.4 Video Detection Systems
5.4 By End User
5.4.1 Hospitals and Ambulatory services
5.4.2 Neurology centers
5.4.3 Diagnostic centers
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medpage Ltd
6.1.2 Boston Scientific Corporation
6.1.3 Cadwell industries
6.1.4 Compumedics USA inc
6.1.5 Emfit Corporation
6.1.6 Empatica Inc
6.1.7 General Electric company
6.1.8 Kninklijke Philips N.V.
6.1.9 Masimo
6.1.10 Neurosoft
6.1.11 Neurowave systems
6.1.12 Nihon Kohden Corporation
6.1.13 Nonin
7 MARKET OPPORTUNITIES AND FUTURE TRENDS